|
|
Governance
In 1984, the New South Wales Parliament passed the Garvan Institute
of Medical Research Act that incorporated Garvan as an autonomous,
non-profit research institute. Garvan's affairs are overseen by two
Boards of Directors: the Garvan Institute and the Garvan Research
Foundation Boards
The Garvan Institute Board is empowered to determine policy and
control the affairs of the Institute as laid down in the NSW Parliament
Garvan Institute of Medical Research Act 1984. The Board approves and
supervises the delegation of authority to committees. Garvan’s Board
meets quarterly and comprises 15 members, nominated by Garvan's various
stakeholders and appointed by the Governor of New South Wales and the
Executive Director of the Institute, who is also appointed by the
Board.
The Garvan Research Foundation Board was established in 1981 to
assist and support the newly-formed Garvan Research Foundation. The
Foundation provides the Institute with an additional source of research
funds by attracting financial support from companies and individuals.
Over the years, the Foundation has evolved to become Garvan's marketing
and fundraising arm. The Garvan Research Foundation Board is subject to
the ultimate direction of the Garvan Institute Board.
William D Ferris AC
Chairman, Nominated by Trustees of St Vincent’s Hospital
 Bill Ferris is Executive Chairman of the
CHAMP Private Equity Group, one of Australia’s leading private capital
groups, providing venture capital, expansion capital and management
buyout funding in Australasia. Mr Ferris is currently Chairman of
International Energy Services Pty Ltd and the Garvan Institute of
Medical Research. Former directorships include: Chairman, Australian
Trade Commission (Austrade) and Austar United Communications Limited,
and Director, Bradken Resources Pty Ltd, Tucker Seabrook (Aust)
Limited, Australian Pacific Paper Products Pty Ltd. He is also a
director of the Garvan Research Foundation.
Martin Hoffman
Treasurer, Nominated by the Sisters of Charity
 Martin Hoffman is CEO of Loop Mobile Limited, a
listed provider of mobile chat and community services internationally.
Prior to that he was Chief Executive Officer of Ninemsn, a 50:50 joint
venture between Microsoft and Publishing & Broadcasting Limited
(PBL). Before joining Ninemsn in February 2003, Martin Hoffman
held a number of senior roles with John Fairfax Holdings Ltd.
Graham J Bradley
Nominated by Garvan Research Foundation
 Graham Bradley is a professional company director. Mr Bradley is Chairman of Stockland Corporation Limited, HSBC Bank Australia Limited and Anglo American Australia Limited. From 1995 to 2003 he was Managing Director of Perpetual Trustees Australia. He is a former partner of McKinsey & Company, management consultants, and a former national managing partner of Blake Dawson Waldron. Mr Bradley was appointed Chairman of Garvan Research Foundation and joined the Garvan Institute Board in 1999.
Nicholas Curtis
Nominated by Trustees of St Vincent’s Hospital
 Nicholas Curtis has a background in investment
banking and the resources industry. He is Executive Chairman of Lynas
Corporation Limited, an Australian public company specialising in rare
earths. Mr Curtis was appointed as Chairman of the Board of St
Vincent’s & Mater Health Sydney in August 2004 and also serves as a
director of the Sisters of Charity Health Service.
Lisa McIntyre
Nominated by Federal Minister for Health
 Dr Lisa McIntyre is a partner with the strategy
consulting firm LEK Consulting and head of LEK¹s Asia Pacific Life
Sciences practice. She has over 15 years consulting for the
biotechnology sector and has worked with over 100 different
biotechnology and life sciences clients primarily focusing on the
challenges associated with commercialising innovation. Dr McIntyre
relocated to Sydney in 2002 after nine years in the United States
co-heading LEK¹s Life Sciences practice where she advised many of the
world¹s leading biotechnology companies. She is also a Director of
Biotech Capital Ltd and AtCor Medical Pty Ltd.
Greg Paramor
Nominated by Garvan Research Foundation
 Greg Paramor has been involved in the real estate
and property funds management industry for approximately 35 years. Mr
Paramor is the former Managing Director of the Mirvac Group following
the acquisition of the James Fielding Group in January 2005. He is the
past President of the Property Council of Australia and the Investment
Funds Association of Australia. He is currently a director of a number
of companies, including the National Breast Cancer Foundation. He
is a Fellow of the Australian Property Institute and a Fellow of The
Royal Chartered Institute of Surveyors.
Sister Carol Pedersen RSC
Nominated by the Sisters of Charity
 Carol Pedersen graduated as a trained
nurse at St Vincent’s Sydney in 1963 and is a Sister of Charity. She
holds a PhD from UNSW and a BSW (Hons 1) from the same institution. She
also holds an Advanced Diploma from the Sydney College of Homoeopathic
Medicine, and recently completed postgraduate work, obtaining an
Associate Diploma in Advanced Homoeopathic Medicine. For over 20 years
Sr Carol was a member of various human research ethics committees, and
was active at national, state and local levels in the development of
Alcohol and Drug Services. Sr Carol lives and works in South West
Sydney where she provides pro bono homoeopathic consultations for the
poor.In 2008 Sr Carol will take this service to rural areas.
Warren Scott
Nominated by NSW Minister for Health
 Warren Scott is a director of Citigroup and is General Counsel and Managing Director in Australia. He is Chairman, Woolcock Institute of Medical Research, as well as a delegate to the Australian American Leadership Dialogue, the Law Society of New South Wales, the American Bar Association, the New York Bar Association and the California Bar Association. Warren is admitted as a solicitor in New South Wales and as a lawyer in New York and California.
John Shine AO FAA
Appointed by Garvan Institute Board
 Professor John Shine is Executive Director of the Garvan Institute of Medical Research and a board member of the Garvan Research Foundation. He is Professor of Molecular Biology and Professor of Medicine at the University of NSW, and a Director of many scientific, research and medical bodies throughout Australia, including the recent ex-Chairman of the National Health and Medical Research Council (NHMRC). Professor Shine is also a member of the Prime Minister’s Science, Engineering & Innovation Council (PMSEIC).
Peter J Smith
Nominated by University of NSW
 Professor Smith is Dean, Faculty of Medicine, the
University of New South Wales. He specialised in cancer medicine
and research following study in Australia, USA and Germany. He has held
senior hospital management posts in Brisbane and Melbourne, senior
academic appointments at the Universities of Queensland, Melbourne and
Auckland. He has served in a consulting role to Government, including
as Chair of the recent Inquiry into Vietnam Veterans Cancer Incidence
and Mortality. Professor Smith is currently a Director of St Vincents
and Mater Health Sydney, NewSouth Innovations, MedSys Assurance (NZ)
and a number of research centres and institutes.
Bernadette Tobin
Nominated by Trustees of St Vincent’s Hospital
 Associate Professor Bernadette Tobin is Director of the Plunkett Centre for Ethics at St Vincent’s Hospital, Sydney, and Reader in Philosophy at Australian Catholic University. Dr Tobin is Honorary Ethicist at the Children’s Hospital at Westmead, Honorary Associate Professor in the Faculty of Medicine at the University of Sydney, and Conjoint Associate Professor in the School of Medicine at the University of New South Wales. She served for three triennia on the Australian Health Ethics Committee, a principal committee of the NHMRC. She also chaired the drafting group which prepared the first Code of Ethics for Catholic Health and Aged Care Services in Australia.
Ronald JA Trent
Nominated by Federal Minister for Health
 Ronald Trent is Professor of Molecular Genetics,
University of Sydney and Head of the Department of Molecular and
Clinical Genetics, Royal Prince Alfred Hospital. He is the Executive
Director of SUPAMAC, the University’s high throughput DNA analysis
service. He has been a member of the NHMRC Research Committee
since, 1997 and is Chairman of the NHMRC Human Genetics Advisory
Committee as well as a member of the NHMRC Council.
Chairman. Graham Bradley is a professional company director. Mr. Bradley is Chairman of Stockland Corporation Limited, HSBC Bank Australia Limited and Anglo American Australia Limited. From 1995 to 2003 he was Managing Director of Perpetual Trustees Australia. He is a former partner of McKinsey & Company, management consultants, and a former national managing partner of Blake Dawson Waldron. Mr. Bradley was appointed Chairman of Garvan Research Foundation and joined the Garvan Institute Board in 1999.
 Jane is the Managing Partner at Egon Zehnder
International Sydney office, the world's largest privately held search
firm with more than 300 consultants located in 62 wholly owned offices
in 36 countries. The firm specialises in senior level executive search,
board consulting and director search, management appraisals, and talent
management. Jane has been at Egon Zehnder International for eight years
where she also leads the Consumer Products Practice Group across Asia
Pacific, including India, China, Japan, and South East Asia as well as
Australia/New Zealand. Prior to joining Egon Zehnder International Jane
worked at Procter & Gamble in both sales and marketing in the US
and Australia. Jane has an MBA from Harvard Business School and a
Bachelor of Arts from Smith College.
 Alec Brennan pursues a portfolio of business and
not for profit interests. Until March 2007, he was CEO and Managing
Director of CSR Limited. He is Chairman of publicly listed Emeco
Limited, Chairman and co-investor in privately owned PPI Limited and
Chairman of Tomago Aluminium Pty Ltd. He is a Fellow of the Senate of
Sydney University and Chair of several of its committees. Mr Brennan
joined the Foundation Board in 2000.
 Originally trained in law and management,
Mr Clark has led the successful growth and development of two of
Australia¹s largest law firms, Minter Ellison and Mallesons Stephen
Jaques as Managing Partner and CEO. Mr Clark is a member of the JP
Morgan Advisory Council, Chairman of the Higher Education Endowment
Fund Advisory Board and a director of ING Management Ltd, CRI Asset
Management Limited, M+K Lawyers Holdings Ltd, St James Ethics Centre
and two scholarship foundations. He joined the Board in 2005.
 Melinda Conrad is former Managing Director and
Founder of the retail store chain, Conrads Warehouse. Prior to her
establishment of Conrads, she held management roles at Harvard Business
School and Colgate-Palmolive. Ms Conrad is also a director of the
Australian Brandenburg Orchestra. Ms Conrad joined the Foundation
Board in September 2003.
Bill Ferris is Executive Chairman of the
CHAMP Private Equity Group, one of Australia’s leading private capital
groups, providing venture capital, expansion capital and management
buyout funding in Australasia. Mr Ferris is currently Chairman of
International Energy Services Pty Ltd and the Garvan Institute of
Medical Research. Former directorships include: Chairman, Australian
Trade Commission (Austrade) and Austar United Communications Limited;
Director, Bradken Resources Pty Ltd, Tucker Seabrook (Aust) Limited,
and Australian Pacific Paper Products Pty Ltd.
 Lyn Gearing was appointed to the Garvan Foundation
board in 2005 as a representative of the Sisters of Charity. Ms Gearing
is a Director of Stockland Corporation Limited, Hancock Natural
Resources Group Australasia Pty Limited and IMB Limited and two other
not for profit organisations. Ms Gearing was the CEO of the NSW State
Superannuation schemes from 1997 to 2002, and has substantial
experience in superannuation, funds management, corporate finance and
management consulting.
 Meredith Hellicar is a company director and
consultant in strategy and change. She is Chairman of AMP Life and the
Sydney Institute and a director of AMP Limited, AMP Bank and
Amalgamated Holdings. Meredith is a member of the Takeovers Panel and
was awarded a Centenary Medal for Business Leadership. Her former
directorships include Chairman of James Hardie Industries and of HLA
Envirosciences, Director of Southern Cross Airports Group, NSW Treasury
Corporation, AurionGold and the NSW Environment Protection Authority.
Previous executive roles include Managing Director of InTech Financial
Services, Chief Executive Officer of Corrs Chambers Westgarth and
Managing Director of TNT Logistics Asia. Ms Hellicar joined the
Foundation Board in March 2002.
 Byram Johnston OAM is the Chief Executive
Officer of MainstreamBPO, a company providing back office processing
and administration services to fund managers and superannuation funds.
Prior to establishing this business he spent over 30 years as a
management consultant. He serves on the board of a number of
companies. He joined the Foundation Board in 1997.
 John Koch is Chief Representative of the Hong Kong based Forma Group of Companies, a former board member of St Vincent’s Hospital and Chair of its Finance Committee. He is Chair, Woods Cottage Foundation which assists intellectually disabled young adults. He had a 32 year career with the Commonwealth Bank assuming a range of domestic and international responsibilities. Mr Koch joined the Foundation Board in 2000.
 Mr Landerer is a Solicitor specialising in
corporate advisory work and is also a professional company
director. He has served as Chairman of the Home Purchase
Assistance Authority and is on the Board of Life Education Australia
and the Royal Institute for Deaf and Blind Children as well as on the
Boards of various charitable institutions. Mr Landerer was appointed a
Visiting Professor at Macquarie University in Business and Commercial
Law and holds an honorary doctorate from that University. He is
also a Fellow of Sydney University. Mr Landerer is a Member of the
Order of Australia and a Commander of the Most Excellent Order of the
British Empire.
 Sister Paulina has a broad background in health policy formation, having been a member of the Hospitals and Health Services Commission (Sax Commission) and Assistant Director General, Nursing Branch, Federal Department of Health. Sister Paulina resigned from the Garvan Institute Board in February 2000 and has been a member of the Foundation Board since 1994.
 Carole Renouf has built her career in the not-for-profit sector. She is a marketing, communications and fundraising professional, who has also trained in management at the Australian Graduate School of Management. Initially, Carole worked in the fields of health and education, including a stint at NSW Health and setting up her own business producing print and audio-visual resources. Carole spent eight years at the Australian Consumers’ Association as a senior policy officer, consumer advocate and media spokesperson. She then spent four years as Director of Fundraising and Communications at WWF Australia. Just prior to taking up her position as Director of the Garvan Research Foundation, she was Director of Marketing and Development for the Faculty of Science at UNSW.
Professor John Shine is Executive Director of the Garvan Institute of Medical Research and a board member of the Garvan Research Foundation. He is Professor of Molecular Biology and Professor of Medicine at the University of NSW, and a Director of many scientific, research and medical bodies throughout Australia, including the recent ex-Chairman of the National Health and Medical Research Council (NHMRC). Professor Shine is also a member of the Prime Minister’s Science, Engineering & Innovation Council (PMSEIC).
 The Hon Warwick Smith is Chairman of the
Advisory Board of Australian Capital Equity where he has a strategic
focus on international and domestic cross-sector activities. He is
Chairman of NSW for the ANZ Bank, and of E*TRADE. Formerly,
Warwick was an Executive Director with Macquarie Bank operating as
Global Head of the Corporate Communications Division and chaired the
Telecommunications, Media, Entertainment and Technology Group within
Investment Banking. In a 15 year Parliamentary career he served as a
Federal Government Minister and in a variety of public roles. He was
Australia’s first Telecommunications Ombudsman. Warwick has a strong
focus on international affairs. He is the Immediate Past Chair of
the Australia China Business Council, the Deputy Chair of the Asia
Society of Australia and a board member of the Global Foundation. He
joined the Board in 2007.
 Mr Wade is currently a consultant to a major
financial services organisation and a company director. Peter
previously spent over 25 years providing investment banking and
financial advice with JBWere and its current form, Goldman Sachs
JBWere; more recently he was with JPMorgan. He worked for nearly 15
years in Europe and the United States before returning to Australia. He
is a Director of MMC Contrarian Limited, an ASX listed company.
 Dick Warburton is currently
Chairman of the Board of Taxation, Magellan Flagship Fund, and Tandou
Limited. He is a director of Note Printing Australia, Citibank and
Caltex Australia. He holds various other positions on committees and
advisory boards within Australia. Mr Warburton is a former Chairman and
CEO of DuPont Australia and New Zealand, whom he has worked with for 30
years. Mr Warburton joined the Foundation Board in 1999.
|
